Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 20

1.

A landscape effect in tenosynovial giant-cell tumor from activation of CSF1 expression by a translocation in a minority of tumor cells.

West RB, Rubin BP, Miller MA, Subramanian S, Kaygusuz G, Montgomery K, Zhu S, Marinelli RJ, De Luca A, Downs-Kelly E, Goldblum JR, Corless CL, Brown PO, Gilks CB, Nielsen TO, Huntsman D, van de Rijn M.

Proc Natl Acad Sci U S A. 2006 Jan 17;103(3):690-5. Epub 2006 Jan 6.

2.

Molecular pathways involved in synovial cell inflammation and tumoral proliferation in diffuse pigmented villonodular synovitis.

Fiocco U, Sfriso P, Lunardi F, Pagnin E, Oliviero F, Scagliori E, Cozzi L, Vezzù M, Molena B, Scanu A, Panziera C, Nardacchione R, Rubaltelli L, Dayer JM, Calabrese F, Punzi L.

Autoimmun Rev. 2010 Sep;9(11):780-4. doi: 10.1016/j.autrev.2010.07.001. Epub 2010 Jul 8. Review.

PMID:
20620241
3.

Treatment of tenosynovial giant cell tumor and pigmented villonodular synovitis.

Ravi V, Wang WL, Lewis VO.

Curr Opin Oncol. 2011 Jul;23(4):361-6. doi: 10.1097/CCO.0b013e328347e1e3. Review.

PMID:
21577109
4.

Current Systemic Treatment Options for Tenosynovial Giant Cell Tumor/Pigmented Villonodular Synovitis: Targeting the CSF1/CSF1R Axis.

Brahmi M, Vinceneux A, Cassier PA.

Curr Treat Options Oncol. 2016 Feb;17(2):10. doi: 10.1007/s11864-015-0385-x. Review.

PMID:
26820289
5.

Giant cell tumor of tendon sheath, tenosynovial giant cell tumor, and pigmented villonodular synovitis: defining the presentation, surgical therapy and recurrence.

Martin RC 2nd, Osborne DL, Edwards MJ, Wrightson W, McMasters KM.

Oncol Rep. 2000 Mar-Apr;7(2):413-9. Review.

PMID:
10671695
6.

Chromosome aberrations in tenosynovial giant cell tumors and nontumorous synovial tissue.

Mertens F, Orndal C, Mandahl N, Heim S, Bauer HF, Rydholm A, Tufvesson A, Willén H, Mitelman F.

Genes Chromosomes Cancer. 1993 Apr;6(4):212-7. Review.

PMID:
7685623
7.

Malignant giant cell tumor of synovium (malignant pigmented villonodular synovitis).

Layfield LJ, Meloni-Ehrig A, Liu K, Shepard R, Harrelson JM.

Arch Pathol Lab Med. 2000 Nov;124(11):1636-41. Review.

PMID:
11079016
8.

Tenosynovial giant cell tumor: case report and review.

Lucas DR.

Arch Pathol Lab Med. 2012 Aug;136(8):901-6. doi: 10.5858/arpa.2012-0165-CR. Review.

PMID:
22849738
9.

Pigmented villonodular synovitis therapy with MSCF-1 inhibitors.

Temple HT.

Curr Opin Oncol. 2012 Jul;24(4):404-8. doi: 10.1097/CCO.0b013e328354c16b. Review.

PMID:
22572726
10.

Cytogenetic characterization of tenosynovial giant cell tumors (nodular tenosynovitis).

Dal Cin P, Sciot R, Samson I, De Smet L, De Wever I, Van Damme B, Van den Berghe H.

Cancer Res. 1994 Aug 1;54(15):3986-7. Review.

11.

Pigmented villonodular bursitis/diffuse giant cell tumor of the pes anserine bursa: a report of two cases and review of literature.

Maheshwari AV, Muro-Cacho CA, Pitcher JD Jr.

Knee. 2007 Oct;14(5):402-7. Epub 2007 Jul 31. Review.

PMID:
17669658
12.

CSF-1R Inhibitor Development: Current Clinical Status.

Peyraud F, Cousin S, Italiano A.

Curr Oncol Rep. 2017 Sep 5;19(11):70. doi: 10.1007/s11912-017-0634-1. Review.

PMID:
28875266
13.

Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors. Dermatofibrosarcoma protuberans and giant cell fibroblastoma.

Sandberg AA, Bridge JA.

Cancer Genet Cytogenet. 2003 Jan 1;140(1):1-12. Review. No abstract available.

PMID:
12550751
14.

Extra-articular diffuse tenosynovial giant cell tumour of the infratemporal fossa: report of a case and literature review.

Gong ZC, Lin ZQ, Moming A, Ling B, Liu H, Hu M, Long X.

Int J Oral Maxillofac Surg. 2010 Aug;39(8):820-4. doi: 10.1016/j.ijom.2010.02.026. Epub 2010 Apr 21. Review.

PMID:
20409688
15.

A new cytogenetic subgroup in tenosynovial giant cell tumors (nodular tenosynovitis) is characterized by involvement of 16q24.

Dal Cin P, Scoit R, De Smet L, Van Damme B, Van Den Berghe H.

Cancer Genet Cytogenet. 1996 Mar;87(1):85-7. Review.

PMID:
8646750
16.

Pathology of the synovium.

O'Connell JX.

Am J Clin Pathol. 2000 Nov;114(5):773-84. Review.

PMID:
11068553
17.

Colony-stimulating factor 1 receptor (CSF1R) inhibitors in cancer therapy.

Cannarile MA, Weisser M, Jacob W, Jegg AM, Ries CH, Rüttinger D.

J Immunother Cancer. 2017 Jul 18;5(1):53. doi: 10.1186/s40425-017-0257-y. Review.

18.

Tumors and diseases of the joint.

Nielsen GP, Rosenberg AE, O'Connell JX, Kattapuram SV, Schiller AL.

Semin Diagn Pathol. 2011 Feb;28(1):37-52. Review.

PMID:
21675376
19.

Diffuse-type tenosynovial giant cell tumour: Current treatment concepts and future perspectives.

Staals EL, Ferrari S, Donati DM, Palmerini E.

Eur J Cancer. 2016 Aug;63:34-40. doi: 10.1016/j.ejca.2016.04.022. Epub 2016 Jun 5. Review.

PMID:
27267143
20.

Pigmented villonodular synovitis.

Mendenhall WM, Mendenhall CM, Reith JD, Scarborough MT, Gibbs CP, Mendenhall NP.

Am J Clin Oncol. 2006 Dec;29(6):548-50. Review.

PMID:
17148989

Supplemental Content

Support Center